Format
Sort by

Send to

Choose Destination

Search results

Items: 20

1.

Ductal metaplasia in oesophageal submucosal glands is associated with inflammation and oesophageal adenocarcinoma.

Garman KS, Kruger L, Thomas S, Swiderska-Syn M, Moser BK, Diehl AM, McCall SJ.

Histopathology. 2015 Dec;67(6):771-82. doi: 10.1111/his.12707. Epub 2015 Jun 4.

PMID:
25847432
2.

Pleiotrophin regulates the ductular reaction by controlling the migration of cells in liver progenitor niches.

Michelotti GA, Tucker A, Swiderska-Syn M, Machado MV, Choi SS, Kruger L, Soderblom E, Thompson JW, Mayer-Salman M, Himburg HA, Moylan CA, Guy CD, Garman KS, Premont RT, Chute JP, Diehl AM.

Gut. 2016 Apr;65(4):683-92. doi: 10.1136/gutjnl-2014-308176. Epub 2015 Jan 16.

3.

Cellular origins and molecular mechanisms of Barrett's esophagus and esophageal adenocarcinoma.

Fang Y, Chen X, Bajpai M, Verma A, Das KM, Souza RF, Garman KS, Donohoe CL, O'Farrell NJ, Reynolds JV, Dvorak K.

Ann N Y Acad Sci. 2013 Oct;1300:187-99. doi: 10.1111/nyas.12249. Review.

PMID:
24117642
4.

MicroRNA expression differentiates squamous epithelium from Barrett's esophagus and esophageal cancer.

Garman KS, Owzar K, Hauser ER, Westfall K, Anderson BR, Souza RF, Diehl AM, Provenzale D, Shaheen NJ.

Dig Dis Sci. 2013 Nov;58(11):3178-88. doi: 10.1007/s10620-013-2806-7. Epub 2013 Aug 8.

5.

Feasibility, safety, acceptability, and yield of office-based, screening transnasal esophagoscopy (with video).

Peery AF, Hoppo T, Garman KS, Dellon ES, Daugherty N, Bream S, Sanz AF, Davison J, Spacek M, Connors D, Faulx AL, Chak A, Luketich JD, Shaheen NJ, Jobe BA; Barrett's Esophagus Risk Consortium.

Gastrointest Endosc. 2012 May;75(5):945-953.e2. doi: 10.1016/j.gie.2012.01.021. Epub 2012 Mar 16.

6.

Review: Experimental models for Barrett's esophagus and esophageal adenocarcinoma.

Garman KS, Orlando RC, Chen X.

Am J Physiol Gastrointest Liver Physiol. 2012 Jun 1;302(11):G1231-43. doi: 10.1152/ajpgi.00509.2011. Epub 2012 Mar 15. Review.

7.

Retraction: Acharya CR, et al. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer. JAMA. 2008;299(13):1574-1587.

Acharya CR, Hsu DS, Anders CK, Anguiano A, Salter KH, Walters KS, Redman RC, Tuchman SA, Moylan CA, Mukherjee S, Barry WT, Dressman HK, Ginsburg GS, Marcom KP, Garman KS, Lyman GH, Nevins JR, Potti A.

JAMA. 2012 Feb 1;307(5):453. doi: 10.1001/jama.2012.2. Epub 2012 Jan 6. No abstract available.

PMID:
22228686
8.

Retraction for Garman et al: A genomic approach to colon cancer risk stratification yields biologic insights into therapeutic opportunities.

Garman KS, Acharya CR, Edelman E, Grade M, Gaedcke J, Sud S, Barry W, Diehl AM, Provenzale D, Ginsburg GS, Ghadimi BM, Ried T, Nevins JR, Mukherjee S, Hsu D, Potti A.

Proc Natl Acad Sci U S A. 2011 Oct 18;108(42):17569. doi: 10.1073/pnas.1115170108. Epub 2011 Oct 3. No abstract available.

9.

Ablative therapies for Barrett's esophagus.

Garman KS, Shaheen NJ.

Curr Gastroenterol Rep. 2011 Jun;13(3):226-39. doi: 10.1007/s11894-011-0182-z. Review.

10.
11.

A genomic approach to colon cancer risk stratification yields biologic insights into therapeutic opportunities.

Garman KS, Acharya CR, Edelman E, Grade M, Gaedcke J, Sud S, Barry W, Diehl AM, Provenzale D, Ginsburg GS, Ghadimi BM, Ried T, Nevins JR, Mukherjee S, Hsu D, Potti A.

Proc Natl Acad Sci U S A. 2008 Dec 9;105(49):19432-7. doi: 10.1073/pnas.0806674105. Epub 2008 Dec 2. Erratum in: Proc Natl Acad Sci U S A. 2009 Apr 21;106(16):6878. Retraction in: Garman KS, Acharya CR, Edelman E, Grade M, Gaedcke J, Sud S, Barry W, Diehl AM, Provenzale D, Ginsburg GS, Ghadimi BM, Ried T, Nevins JR, Mukherjee S, Hsu D, Potti A. Proc Natl Acad Sci U S A. 2011 Oct 18;108(42):17569.

12.

Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer.

Acharya CR, Hsu DS, Anders CK, Anguiano A, Salter KH, Walters KS, Redman RC, Tuchman SA, Moylan CA, Mukherjee S, Barry WT, Dressman HK, Ginsburg GS, Marcom KP, Garman KS, Lyman GH, Nevins JR, Potti A.

JAMA. 2008 Apr 2;299(13):1574-87. doi: 10.1001/jama.299.13.1574. Retraction in: Acharya CR, Hsu DS, Anders CK, Anguiano A, Salter KH, Walters KS, Redman RC, Tuchman SA, Moylan CA, Mukherjee S, Barry WT, Dressman HK, Ginsburg GS, Marcom KP, Garman KS, Lyman GH, Nevins JR, Potti A. JAMA. 2012 Feb 1;307(5):453.

PMID:
18387932
13.

An integrated approach to the prediction of chemotherapeutic response in patients with breast cancer.

Salter KH, Acharya CR, Walters KS, Redman R, Anguiano A, Garman KS, Anders CK, Mukherjee S, Dressman HK, Barry WT, Marcom KP, Olson J, Nevins JR, Potti A.

PLoS One. 2008 Apr 2;3(4):e1908. doi: 10.1371/journal.pone.0001908. Retraction in: PLoS One. 2011;6(9). doi: 10.1371/annotation/8f94e479-4161-43a0-a28c-4c0460bb89a4.

14.

Genomic strategies for personalized cancer therapy.

Garman KS, Nevins JR, Potti A.

Hum Mol Genet. 2007 Oct 15;16 Spec No. 2:R226-32. Review.

15.

Clinical diagnostic reasoning.

Echols MR, Garman KS, Lyles KW.

N Engl J Med. 2007 Mar 22;356(12):1272; author reply 1273-4. No abstract available.

PMID:
17380583
16.

Colorectal cancer screening, comorbidity, and follow-up in elderly patients.

Garman KS, Jeffreys A, Coffman C, Fisher DA.

Am J Med Sci. 2006 Oct;332(4):159-63.

PMID:
17031239
17.

Apolipoprotein E epsilon4 allele increases risk for psychotic symptoms in Alzheimer's disease.

Zdanys KF, Kleiman TG, MacAvoy MG, Black BT, Rightmer TE, Grey M, Garman KS, Tampi RR, Gelernter J, van Dyck CH.

Neuropsychopharmacology. 2007 Jan;32(1):171-9. Epub 2006 Jul 12.

18.
19.

Function in elderly cancer survivors depends on comorbidities.

Garman KS, Pieper CF, Seo P, Cohen HJ.

J Gerontol A Biol Sci Med Sci. 2003 Dec;58(12):M1119-24.

PMID:
14684709
20.

Functional status and the elderly cancer patient.

Garman KS, Cohen HJ.

Crit Rev Oncol Hematol. 2002 Sep;43(3):191-208. Review.

PMID:
12270776
Items per page

Supplemental Content

Loading ...
Write to the Help Desk